Sequencing data of cell-free DNA fragments in living-related liver transplantation for inborn errors of metabolism.
Fragment size
Graft derived cell-free DNA
Inborn errors of metabolism
Living-related liver transplantation
Journal
Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
15
03
2019
revised:
16
01
2020
accepted:
17
01
2020
entrez:
20
2
2020
pubmed:
20
2
2020
medline:
20
2
2020
Statut:
epublish
Résumé
Graft derived cell-free DNA was recently reported as a non-invasive biomarker to detect graft damage or rejection after liver transplantation. There are a number of methods for quantification of Gcf-DNA, including quantitative-PCR, digital droplet PCR and massively parallel sequencing (next generation sequencing). Here we present the NGS data and fragment size distribution of cell-free DNA in the plasma of patients with inborn errors of metabolism who underwent living-related liver transplantation. For more insights please see Analysis of fragment size distribution of cell-free DNA: a potential noninvasive marker to monitor graft damage in living-related liver transplantation for inborn errors of metabolism. [1].
Identifiants
pubmed: 32071968
doi: 10.1016/j.dib.2020.105183
pii: S2352-3409(20)30077-9
pii: 105183
pmc: PMC7013363
doi:
Types de publication
Journal Article
Langues
eng
Pagination
105183Informations de copyright
© 2020 The Author(s).
Références
PLoS One. 2016 Jul 21;11(7):e0159648
pubmed: 27441628
Mol Genet Metab. 2019 May;127(1):45-50
pubmed: 31027872